Buprenorphine Hydrochloride
Product Images NDC 64725-0930

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 64725-0930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0930)

Label for buprenorphine hydrochloride sublingual tablets 0.8 mg, repackaged by T.Y.A. Pharmaceuticals. The label includes prescription-only designation, no lot number, an unreadable expiration date, manufacturer listed as Hi-Tech, repackager contact information in Tallahassee, FL, and a barcode. Dose instructions refer to the package insert.*

FDA Label Image

Chemical Structure (Buprenorphine Hydrochloride 1)

Chemical structure of buprenorphine hydrochloride showing its molecular framework with hydroxyl, methoxy, and cyclopropyl groups, as well as characteristic ring structures.*

FDA Label Image

Figure (Buprenorphine Hydrochloride 2)

An instructional illustration showing a person placing a buprenorphine hydrochloride tablet under the tongue for sublingual administration. The image highlights proper placement for the medication to dissolve in the mouth.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.